Bosh sahifaASRT • NASDAQ
add
Assertio Holdings Inc
0,66 $
Seans yopilganidan keyin:(0,38%)-0,0025
0,66 $
Yopilgan:10-iyn, 17:16:31 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
0,66 $
Kunlik diapazon
0,66 $ - 0,67 $
Yillik diapazon
0,51 $ - 1,80 $
Bozor kapitalizatsiyasi
63,47 mln USD
Oʻrtacha hajm
254,89 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 26,49 mln | -18,37% |
Joriy xarajat | 31,65 mln | 27,15% |
Sof foyda | -13,54 mln | -200,24% |
Sof foyda marjasi | -51,12 | -267,77% |
Har bir ulushga tushum | -0,04 | -200,00% |
EBITDA | -3,68 mln | -276,77% |
Amaldagi soliq stavkasi | -1,84% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 87,32 mln | 8,15% |
Jami aktivlari | 286,43 mln | 1,58% |
Jami passivlari | 177,90 mln | 20,63% |
Umumiy kapital | 108,53 mln | — |
Tarqatilgan aksiyalar | 95,78 mln | — |
Narxi/balansdagi bahosi | 0,58 | — |
Aktivlardan daromad | -11,33% | — |
Kapitaldan daromad | -20,87% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -13,54 mln | -200,24% |
Operatsiyalardan naqd pul | -12,54 mln | -267,00% |
Sarmoyadan naqd pul | -2,94 mln | — |
Moliyadan naqd pul | -111,00 ming | 46,12% |
Naqd pulning sof oʻzgarishi | -15,58 mln | -313,42% |
Boʻsh pul | -7,64 mln | -182,12% |
Haqida
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
Tashkil etilgan
1995
Sayt
Xodimlar soni
58
